To: Nine_USA who wrote (25123 ) 12/8/1999 7:53:00 AM From: Pigboy Respond to of 29386
Thanks for the great reporting ED and Alan. Was a nice day. Oh, wait, that's right. After every nice day in Ancor stock, there JUST HAPPENS to be an article by that Brocade Intern Herby Greenberg. As you all know, Herb LOVES Ancor! Oh my gosh, he is bringing up the Sun deal again...LOL! If anyone wants better entertainment than Herb's false reporting articles (Bob Frasca explains some two posts ahead here on SI), then visit how well Ancor has done since he started losing money for his hedge fund 'mob' buddies...whom I hope covered. ;-)goancr.com Oh, sorry, the article. Yeah, from what I gather from hearing about Brocade speeches and reading Herb's 'well researched' articles ;-), it's simply "Not Smart" according to people like Brocade and Herb to do deals with SUN and Intel. I mean, SUN and Intel are such nobodies in the Internet Revolution. ;-)) Does herb know what 'future' revenues mean? LOL! Wouldn't the better article have been entitled, "How I run Brocade and am such a moron for turning down deals at the two of the three biggest computing companies in the world?" LOL! <<<<<<<<<<<<<<<<<<<<<< Commentary : Herb on TheStreet More on Ancor and Checking Back on MedImmune By Herb Greenberg Senior Columnist 12/8/99 6:30 AM ET Wednesday's Wince All in a day's hype, er, work: A $14.8 million investment by Intel (INTC:Nasdaq) yesterday helped Ancor's (ANCR:Nasdaq) market cap grow by about $650 million in this wacky, fundamentals-don't-mean-anything kinda market. Nothing changed at the company. Nothing! Nothing but the receipt of an investment from Intel regarding a so-called InfiniBand product that, if developed, is two years out. Yet Ancor's stock zoomed on the news, and as you might guess, the Hostile React-o-Meter was spinning outta control in the wake of yesterday's Ancor item. (Actually, it was also spinning because of the MedImmune (MEDI:Nasdaq) item, but that's another story.) Oh, and by the way, SunTrust Equitable analyst Mark Kelleher, an Ancor bull, lowered his rating on the company to attractive long term from strong buy for three sensible reasons. The first was the most obvious: valuation. "While we continue to believe the company's prospects are strong, driven by the growth of the [fiber channel] market," he wrote in a report to clients, "we believe most of the good news is now priced into Ancor's stock, and the risks ... now outweigh the possibility of continued strong stock price appreciation." The second was also obvious: The Intel investment does not call for Intel to take any product or generate any revenue. His final point -- something that has been pointed out here (from the dose-of-reality department): Kelleher noted that the higher Ancor's stock price goes, the less Ancor makes on its much-heralded order from Sun Microsystems (SUNW:Nasdaq). Sun, you'll recall, has warrants in Ancor stock that translate into a discount for Sun as Ancor's stock appreciates. The higher the stock, the steeper the discount. His bottom line: When Ancor's stock reaches 74 1/2, the Sun deal actually generates negative revenue under generally accepted accounting practices. Ancor closed yesterday at 85 7/8. >>>>>>>>>>>>>>>>>>> all imho, pigboy